JV of DSP, Japan BCG to Develop New TB Vaccines with NIBIO, US NPO

November 13, 2013
Create Vaccine, an Osaka-based joint venture of Dainippon Sumitomo Pharma (DSP) and Japan BCG Laboratory, has reached a basic agreement with two external organizations on the joint development of new tuberculosis (TB) vaccines. The two organizations are the National Institute...read more